Lipella Pharms Inc (LIPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 87 | 129 | 174 | 80 |
| Gross Profit | N/A | 87 | 129 | 174 | 80 |
| Operating Expenses | 1,274 | 1,443 | 1,457 | 1,625 | 1,540 |
| Operating Income | -1,274 | -1,357 | -1,328 | -1,451 | -1,459 |
| Other Income | 20 | 29 | 21 | 10 | 15 |
| Pre-tax Income | -1,254 | -1,328 | -1,307 | -1,442 | -1,445 |
| Net Income Continuous | -1,254 | -1,328 | -1,307 | -1,442 | -1,445 |
| Net Income | $-1,254 | $-1,328 | $-1,307 | $-1,442 | $-1,445 |
| EPS Basic Total Ops | -0.28 | -0.31 | -0.64 | -1.20 | -1.29 |
| EPS Basic Continuous Ops | -0.28 | -0.31 | -0.64 | -1.20 | -1.29 |
| EPS Diluted Total Ops | -0.28 | -0.31 | -0.64 | -1.20 | -1.29 |
| EPS Diluted Continuous Ops | -0.28 | -0.31 | -0.64 | -1.20 | -1.29 |
| EPS Diluted Before Non-Recurring Items | -0.28 | -0.31 | -0.64 | -1.19 | -1.29 |
| EBITDA(a) | $-1,274 | $-1,356 | $-1,327 | $-1,451 | $-1,459 |